Oral delivery system for hemoglobin based oxygen carriers
A process for making hemoglobin based oxygen carrier (HBOC) containing pharmaceutical composition suitable for oral delivery and the composition formed thereby are described. There are three exemplary composition configurations which include (1) hemoglobin-loaded nanoparticles solution, (2) enteric-...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
19.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A process for making hemoglobin based oxygen carrier (HBOC) containing pharmaceutical composition suitable for oral delivery and the composition formed thereby are described. There are three exemplary composition configurations which include (1) hemoglobin-loaded nanoparticles solution, (2) enteric-coated hemoglobin capsules and (3) enteric-coated hemoglobin tablets. To facilitate the bioavailability and bio-compatibility of hemoglobin, intestinal absorption enhancers are added in each of the HBOC formulations. Protective layers ensure delivery of an intact hemoglobin structure in intestinal tract without degradation in the stomach. The HBOC formulations may be used for preventive or immediate treatment of high altitude syndrome (HAS) or for treatment of hypoxic conditions including blood loss, anemia, hypoxic cancerous tissue, and other oxygen-deprivation disorders. In addition to delivering oxygen, the heme group of hemoglobin from HBOC formulations can provide heme iron to the human body to aid in the production of more red blood cells. The presently claimed invention provides improved hemoglobin formulations for forming nanoparticles with improved properties via polyelectrolyte complexation and for lyophilization to form mixture powder or particles with improved properties. |
---|---|
AbstractList | A process for making hemoglobin based oxygen carrier (HBOC) containing pharmaceutical composition suitable for oral delivery and the composition formed thereby are described. There are three exemplary composition configurations which include (1) hemoglobin-loaded nanoparticles solution, (2) enteric-coated hemoglobin capsules and (3) enteric-coated hemoglobin tablets. To facilitate the bioavailability and bio-compatibility of hemoglobin, intestinal absorption enhancers are added in each of the HBOC formulations. Protective layers ensure delivery of an intact hemoglobin structure in intestinal tract without degradation in the stomach. The HBOC formulations may be used for preventive or immediate treatment of high altitude syndrome (HAS) or for treatment of hypoxic conditions including blood loss, anemia, hypoxic cancerous tissue, and other oxygen-deprivation disorders. In addition to delivering oxygen, the heme group of hemoglobin from HBOC formulations can provide heme iron to the human body to aid in the production of more red blood cells. The presently claimed invention provides improved hemoglobin formulations for forming nanoparticles with improved properties via polyelectrolyte complexation and for lyophilization to form mixture powder or particles with improved properties. |
Author | Wong Bing Lou Kwok Sui Yi |
Author_xml | – fullname: Kwok Sui Yi – fullname: Wong Bing Lou |
BookMark | eNrjYmDJy89L5WSw9C9KzFFISc3JLEstqlQoriwuSc1VSMsvUshIzc1Pz8lPysxTSEosTk1RyK-oTE_NU0hOLCrKTC0q5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8aHBluZmxhYWlk5GxkQoAQAR5DCq |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US9763889B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US9763889B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:06:47 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US9763889B23 |
Notes | Application Number: US201615016220 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170919&DB=EPODOC&CC=US&NR=9763889B2 |
ParticipantIDs | epo_espacenet_US9763889B2 |
PublicationCentury | 2000 |
PublicationDate | 20170919 |
PublicationDateYYYYMMDD | 2017-09-19 |
PublicationDate_xml | – month: 09 year: 2017 text: 20170919 day: 19 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | Billion King International Ltd |
RelatedCompanies_xml | – name: Billion King International Ltd |
Score | 3.1063666 |
Snippet | A process for making hemoglobin based oxygen carrier (HBOC) containing pharmaceutical composition suitable for oral delivery and the composition formed thereby... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MANUFACTURE OR TREATMENT OF NANOSTRUCTURES MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES MEDICAL OR VETERINARY SCIENCE NANOTECHNOLOGY PERFORMING OPERATIONS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES TRANSPORTING |
Title | Oral delivery system for hemoglobin based oxygen carriers |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170919&DB=EPODOC&locale=&CC=US&NR=9763889B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPkFmwe2ySHIORRitCm2EZ6K9kkC4GSlCRF---djWn1ordllx329c1jd2YW4GmoWlGscCaj6o8GimZSmSXUkBPVHMSM8gEzRLzzZDoch_rrki47kO1jYZo8oR9NckREVIx4rxt-vfm5xPIa38rqmWVYVbyMFrYntdaxYqD4syTPsf1Z4AWu5Lp2OJemb2gs4UEzLQe59RFq0YYAg__uiKCUzW-JMjqH4xkSy-sL6KR5D07d_cdrPTiZtO_dWGyhV12CFZTRmiTpWjhS7Mh3BmaCKifBnoXI65HlRMikhBSfOzwWJI5K8R1ddQVk5C_csYxjWB3muwrnh9Fq19DNizy9AZIyS-OccqpzhlpEbBomj9RYp7gHCqKuD_0_ydz-03YHZ2LhhA-EYt1Dty636QMK2po9Nkv0BZJphCM |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSP42oPprZFCl7aHxqQPggqUCBhupNt2kyakJW2N8u-drQW96G2zm53s65vH7swswH2_a_iBwpmMqj8aKD2dyiykmhx29U7AKO8wTcQ7jyf94UJ9XtJlDeJdLEyZJ_SjTI6IiAoQ70XJrzc_l1hO6VuZP7AYq9LHwdx0pMo6VjQUf4bkWKY79RzPlmzbXMykySsaS3jQdMNCbn2AGrYmwOC-WSIoZfNbogxO4HCKxJLiFGpR0oSGvft4rQlH4-q9G4sV9PIzMLzMX5MwWgtHii35zsBMUOUk2DMVeT3ihAiZFJL0c4vHggR-Jr6jy8-BDNy5PZRxDKv9fFeL2X60vQuoJ2kSXQKJmNHjnHKqcoZaRKBrOve7gUpxDxREXQtaf5Jp_9N2B43hfDxajZ4mL1dwLBZR-EMoxjXUi-w9ukGhW7Dbcrm-AO-UhxY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Oral+delivery+system+for+hemoglobin+based+oxygen+carriers&rft.inventor=Kwok+Sui+Yi&rft.inventor=Wong+Bing+Lou&rft.date=2017-09-19&rft.externalDBID=B2&rft.externalDocID=US9763889B2 |